BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38513960)

  • 21. Volumetric modulated arc therapy of head-and-neck cancer on a fast-rotating O-ring linac: Plan quality and delivery time comparison with a C-arm linac.
    Michiels S; Poels K; Crijns W; Delombaerde L; De Roover R; Vanstraelen B; Haustermans K; Nuyts S; Depuydt T
    Radiother Oncol; 2018 Sep; 128(3):479-484. PubMed ID: 29739713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric Comparison between Volumetric Modulated Arc Therapy (VMAT) and Intensity-Modulated Radiotherapy (IMRT) for Dental Structures of Head and Neck Cancer Patients.
    Ma Y; Zhou J; Wang H
    J Healthc Eng; 2022; 2022():4998997. PubMed ID: 35422981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMRT for head and neck cancer: reducing xerostomia and dysphagia.
    Wang X; Eisbruch A
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i69-i75. PubMed ID: 27538846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric comparison of head and neck cancer patients planned with multivendor volumetric modulated arc therapy technology.
    Kathirvel M; Subramani V; Subramanian VS; Swamy ST; Arun G; Kala S
    J Cancer Res Ther; 2017; 13(1):122-130. PubMed ID: 28508845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
    Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
    Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
    Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between plan quality improvements and reduced acute dysphagia and xerostomia in the definitive treatment of oropharyngeal squamous cell carcinoma.
    Cui T; Ward MC; Joshi NP; Woody NM; Murray EJ; Potter J; Dorfmeyer AA; Greskovich JF; Koyfman SA; Xia P
    Head Neck; 2019 Apr; 41(4):1096-1103. PubMed ID: 30702180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Multi-Criteria Optimization-based Trade-Off exploration in combination with RapidPlan for head & neck radiotherapy planning.
    Miguel-Chumacero E; Currie G; Johnston A; Currie S
    Radiat Oncol; 2018 Nov; 13(1):229. PubMed ID: 30470254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
    Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric comparison of O-ring versus conventional C-arm linear accelerator for volumetric modulated arc therapy (VMAT) of head and neck cancer and carcinoma cervix patients.
    Patodi V; Soni TP; Singh DK; Patni N; Jakhotia N; Chittappurath V; Kuyyanangadan R; Jenny A; Kanniyappan E; Gupta AK; Gupta TC; Singhal H; Natrajan T; Kather FS
    Radiat Prot Dosimetry; 2024 Apr; 200(6):538-543. PubMed ID: 38441907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protons in head-and-neck cancer: bridging the gap of evidence.
    Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands.
    Walser MA; Bachmann N; Kluckert J; Köthe A; Tully C; Leiser D; Lomax AJ; Bizzocchi N; Langendijk JA; Weber DC
    Br J Radiol; 2023 Aug; 96(1148):20220672. PubMed ID: 37129312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of standard intensity-modulated radiotherapy and RapidArc planning techniques for ipsilateral and bilateral head and neck irradiation.
    Pursley J; Damato AL; Czerminska MA; Margalit DN; Sher DJ; Tishler RB
    Med Dosim; 2017 Spring; 42(1):31-36. PubMed ID: 27919621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer: A comparative analysis of dosimetry for target volume and organs at risk.
    Akiyama H; Pesznyák C; Béla D; Ferenczi Ö; Major T; Polgár C; Takácsi-Nagy Z
    Radiol Oncol; 2018 Nov; 52(4):461-467. PubMed ID: 30422804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancer.
    Thomson DJ; Beasley WJ; Garcez K; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
    Med Dosim; 2016; 41(2):154-8. PubMed ID: 26993081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can volumetric modulated arc radiation therapy reduce organ at risk dose in stage 4 sinonasal tumors in dogs treated with boost irradiation?
    Meier V; Czichon F; Walsh L; Rohrer Bley C
    PLoS One; 2021; 16(10):e0259112. PubMed ID: 34714825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
    Karpf D; Sakka M; Metzger M; Grabenbauer GG
    Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.